SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001068238-23-000182
Filing Date
2023-08-30
Accepted
2023-08-30 16:15:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 GKCC SCHEDULE 13D immx_sch13d.htm SC 13D 54749
  Complete submission text file 0001068238-23-000182.txt   56237
Mailing Address 10573 W. PICO BLVD. #58 LOS ANGELES CA 90064
Business Address 11400 WEST OLYMPIC BLVD. SUITE 200 LOS ANGELES CA 90064 (888) 958-1084
Immix Biopharma, Inc. (Subject) CIK: 0001873835 (see all company filings)

IRS No.: 454869378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-93202 | Film No.: 231225415
SIC: 2834 Pharmaceutical Preparations

Mailing Address 501 SILVERSIDE ROAD SUITE 87AVA WILMINGTON DE 19809
Business Address 501 SILVERSIDE ROAD SUITE 87AVA WILMINGTON DE 19809 (302) 992-8882
GKCC, LLC (Filed by) CIK: 0001977769 (see all company filings)

IRS No.: 472175589 | State of Incorp.: DE
Type: SC 13D